rel="nofollow" href="#ulink_6f30e61a-126b-5931-a504-e44035e88ec6">
Miscellaneous lipid‐regulating agents
MTP inhibitors
PCSK9 inhibitors
Statins (HMG CoA reductase inhibitors)
References
10 4 Drugs that affect the respiratory system Respiratory disease drugs Antimuscarinics Beta‐2 agonists Corticosteroids Leukotriene receptor antagonists Monoclonal antibodies Phosphodiesterase type‐4 inhibitors Xanthines References
11 5 Drugs that affect the central and peripheral nervous system Antiepileptic drugs Antidepressants Monoamine oxidase inhibitors (MAOIs) Serotonin and/or noradrenaline reuptake inhibitors (SSRI, NRI, SNRI and SMS) Tricyclic antidepressants (TCAs) Miscellaneous antidepressants Antipsychotics First‐generation antipsychotics Second‐generation antipsychotics Second‐generation antipsychotics Benzodiazepines Non‐benzodiazepine sedatives Cyclopyrrolones and imidazopyridines Melatonin receptor agonists Antihistamines Antimuscarinics Parkinson's disease drugs Levodopa and DDI compounds COMT inhibitors Dopamine receptor agonists Monoamine oxidase‐B inhibitors Antimuscarinic antiparkinsonian drugs Glutamate antagonists References
12 6 Drugs used in the management of pain Analgesics Non‐opioid analgesics Compound analgesics Opioid analgesics 5HT‐1 agonists Non‐steroidal anti‐inflammatory drugs (NSAIDs) Enolic acid class NSAIDs Acetic acid, propionic acid and fenamic acid class NSAIDs Cyclo‐oxygenase (COX)‐2 inhibitors References
13 7 Antiemetics: drugs used in the management of nausea and vomiting Antiemetics Analogues of histamine Antihistamine antiemetics Antimuscarinic antiemetics Dopamine receptor antagonists 5HT‐3 receptor antagonists Neurokinin‐1 receptor antagonists Phenothiazines References
14 8 Diabetes drug therapy and other medicines that affect the endocrine system Insulins Short‐acting insulins Intermediate and long‐acting insulins Biphasic insulins
